NEFH and spinal muscular atrophy, type 1: Only in SMA type 1 patients, longer disease duration significantly correlated with lower baseline levels of T‐Tau, NfL and p‐NfH and lower changes of NfL levels from baseline to treatment day 63, 180 and 300.